BTAL logo

AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL)

$11.58

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BTAL

AUM

$287184000

P/E ratio

13.3

Dividend yield

3.2012%

Expense ratio

1.4%

Beta

-0.628646

Price on BTAL

Previous close

$11.84

Today's open

$11.66

Day's range

$11.52 - $11.67

52 week range

$10.86 - $17.36

Profile about BTAL

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

BTAL industries and sectors

Equities

Multi Alternative

News on BTAL

Bitcoin's high conviction holders are turning into sellers as the crypto's price hits new lows

In the past two days, bitcoin's highest conviction holders have sold about $2.4 billion in bitcoin. Of the bitcoin sold in the past 30 days, 26% came from investors who bought it above $90,000.

news source

CNBC • Jun 3, 2026

news preview

Real Assets or Active ETFs? Where RIAs Allocate

Registered investment advisors did not pull back on exchange-traded funds in the first quarter of 2026. They kept adding them, according to AdvizorPro's Q1 2026 Quarterly RIA ETF Trends Report.

news source

ETF Trends • May 26, 2026

news preview

BTAL: Mea Culpa (Rating Downgrade)

The AGF US Market Neutral Anti-Beta Fund ETF is downgraded from 'Buy' to 'Hold' after significant underperformance and failure to hedge in 2026. BTAL's structure remains sector-neutral, shorting high-beta stocks and going long low-beta names, but poor individual stock selection led to negative -13.9% returns this year. Despite correct macro positioning, BTAL's active management failed to deliver intended negative beta exposure or effective downside protection in 2026.

news source

Seeking Alpha • Apr 23, 2026

news preview

Strategists at Exchange on Navigating the New Correlation Regime

For years, the standard 60/40 portfolio relied on a simple inverse relationship between equities and bonds. However, as volatility spikes, that safety net is fraying, and panelists at Exchange discussed responses to this challenge.

news source

ETF Trends • Mar 17, 2026

news preview

5 ETFs Hovering Around a One-Month High

Commodity and defensive ETFs surged as Iran war tensions rattled markets, pushing several funds close to one-month highs.

news source

Zacks Investment Research • Mar 10, 2026

news preview

BTAL: A Negative Beta Fund As A Portfolio Hedge

AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL) excels as a tactical hedge, not a traditional buy-and-hold investment. BTAL monetizes the spread between low and high beta stocks, thriving in risk-off or overextended market environments. The ETF is delta-neutral by sector, reducing portfolio volatility and drawdowns, and improves Sharpe ratio when paired with equities.

news source

Seeking Alpha • Jan 17, 2026

news preview

Are Anti-Beta ETFs Like BTAL Worth Owning In 2026?

When high-beta stocks stumble and markets turn volatile, AGFiQ U.S. Market Neutral Anti-Beta Fund ( NYSEARCA:BTAL ) is designed to deliver.

news source

24/7 Wall Street • Jan 1, 2026

news preview

BTAL: Unconvincing Long-Short ETF

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is long in 200 low-beta stocks and short in 200 high-beta stocks. BTAL has value characteristics and low company risk, but its track record is uncompelling, with negative return since 2011. FTLS stands out as a superior long-short ETF alternative for investors seeking risk-adjusted performance.

news source

Seeking Alpha • Oct 24, 2025

news preview

BTAL: A Smart, Yet Controversial Hedge To The S&P 500

BTAL offers a market-neutral strategy by going long low-beta and short high-beta U.S. stocks, providing S&P 500 hedging. The ETF plays the low vs. high beta spread, offering stronger short-term hedging and better long-term preservation than classic shorts. In my view, it must be included in a portfolio with a clear strategy; otherwise, it's dead weight, not added value.

news source

Seeking Alpha • Jun 23, 2025

news preview

BTAL Battles With Short, High-Beta Stocks

AGF U.S. Market Neutral Anti-Beta Fund ETF is designed as a market-neutral equity hedge, long low-beta and short high-beta stocks, to benefit investors during market corrections. Despite its intent, the Fund has underperformed benchmarks and is best used only during significant market declines, not as a long-term core holding. Given current market conditions, I recommend a 'Sell' rating on BTAL. Despite my negative sentiment, BTAL could benefit from economic uncertainty and geopolitical risks.

news source

Seeking Alpha • Jun 18, 2025

news preview

¹ Disclosures

Get started with M1

Invest in AGFiQ U.S. Market Neutral Anti-Beta Fund

Open an M1 investment account to buy and sell AGFiQ U.S. Market Neutral Anti-Beta Fund commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BTAL on M1